Coronary DCB: Future Opportunities and Clinical Research Directions
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Grant Support/Research Contract - AstraZenca
- Consultant Fee/Honoraria/Speaker's Bureau - Boston Scientific Corporation